Zobrazeno 1 - 10
of 79
pro vyhledávání: '"Scott J. Johnson"'
Autor:
Jonathan I. Silverberg, H. Chih-ho Hong, Brian M. Calimlim, Wan-Ju Lee, Henrique D. Teixeira, Eric B. Collins, Marjorie M. Crowell, Scott J. Johnson, April W. Armstrong
Publikováno v:
Dermatology and Therapy, Vol 13, Iss 10, Pp 2247-2264 (2023)
Abstract Introduction The treatment landscape for moderate-to-severe atopic dermatitis (AD) continues to expand. This network meta-analysis (NMA) updates a previously conducted NMA to include data from the most recent phase 3 trials to assess the com
Externí odkaz:
https://doaj.org/article/a652da315a6b45c186f4bac0bdfe50c5
Publikováno v:
Energies, Vol 8, Iss 6, Pp 5885-5897 (2015)
This study presents an innovative design of a microtab system for aerodynamic load control on horizontal-axis wind-turbine rotors. Microtabs are small devices located near the trailing edge of the rotor blades and enable a rapid increase or decrease
Externí odkaz:
https://doaj.org/article/ee850f3ac09542bb8a4ff897f93060ba
Publikováno v:
Better Homes & Gardens; Jun2024, Vol. 102 Issue 6, p88-93, 6p, 23 Color Photographs
Autor:
Jonathan I, Silverberg, H Chih-Ho, Hong, Jacob P, Thyssen, Brian M, Calimlim, Avani, Joshi, Henrique D, Teixeira, Eric B, Collins, Marjorie M, Crowell, Scott J, Johnson, April W, Armstrong
Publikováno v:
Silverberg, J I, Hong, H C H, Thyssen, J P, Calimlim, B M, Joshi, A, Teixeira, H D, Collins, E B, Crowell, M M, Johnson, S J & Armstrong, A W 2022, ' Comparative Efficacy of Targeted Systemic Therapies for Moderate to Severe Atopic Dermatitis without Topical Corticosteroids : Systematic Review and Network Meta-analysis ', Dermatology and Therapy, vol. 12, no. 5, pp. 1181-1196 . https://doi.org/10.1007/s13555-022-00721-1
Introduction: The comparative efficacy of targeted systemic therapies for moderate to severe atopic dermatitis (AD) has not been systematically assessed using recent phase 3 data. This network meta-analysis assesses the comparative efficacy of target
Autor:
Ashley Tabah, David Huggar, Si-Tien Wang, Scott J Johnson, Ronda M Copher, Thomas O'Connell, Ali McBride, Thomas W LeBlanc
Publikováno v:
Future oncology (London, England).
Aim: Evaluate the relative efficacy of oral versus injectable azacitidine (AZA) maintenance therapy in acute myeloid leukemia (AML) after complete remission. Materials & methods: Systematic literature review identified QUAZAR AML-001, HOVON 97 AML, U
Autor:
Scott J. Johnson, Sang Kyu Cho, Suchin Virabhak, Beenish S Manzoor, Sheila Shapouri, Simon Sharmokh, Arliene Ravelo, Kavita Sail, Tatyana Kapustyan, H. Parisé, Matthew S. Davids
Publikováno v:
PharmacoEconomics. 38:941-951
This study aimed to assess the total cost of care (TCC) and budget impact of introducing 12-month fixed duration venetoclax + obinutuzumab (VEN+G) as first-line treatment for chronic lymphocytic leukemia (CLL) from the perspective of a US health plan
Autor:
Elizabeth Chertavian, Scott J. Johnson, Margaret E. Gerbasi, Paul Hodgkins, Samantha Meltzer-Brody, Julia C. Bond, Joshua T. Cohen, Adi Eldar-Lissai
Publikováno v:
Journal of Managed Care & Specialty Pharmacy. 26:627-638
Brexanolone injection (BRX) was approved by the FDA in 2019 for the treatment of adult patients with postpartum depression (PPD), but its cost-effectiveness has not yet been evaluated.To estimate the cost-effectiveness of BRX compared with treatment
Autor:
Abhik Bhattacharya, Adam J. Book, Naga Chalasani, Scott J. Johnson, Lewis R. Roberts, David K. Edwards, Brenda M. Neis, Irene Chen, Kong M. Xiong, Janelle J. Bruinsma, Tiruvidaimarudur S. Ramasubramanian, John B. Kisiel, Amit G. Singal, K. Rajender Reddy, Marilyn C. Olson, Kyle Porter
Publikováno v:
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association. 20(1)
BACKGROUND & AIMS Hepatocellular carcinoma (HCC) is a leading cause of cancer-related death worldwide. Although biannual ultrasound surveillance with or without α-fetoprotein (AFP) testing is recommended for at-risk patients, sensitivity for early s
Publikováno v:
ClinicoEconomics and Outcomes Research. 11:257-270
Background Patients with treatment-resistant major depressive disorder (TRD) have limited treatment options. We developed an early stage cost-effectiveness model of TRD to explore the potential value of a hypothetical monotherapy relative to the stan
Autor:
Sarah Pitluck, Thomas A. Ciulla, Natalia Piglowska, Scott J. Johnson, Marric Buessing, Andrew Lloyd, Thomas O'Connell
Publikováno v:
British Journal of Ophthalmology. 103:1610-1614
Background/aimsIn rare diseases, health-related quality of life (HRQL) data can be difficult to capture. Given the ultrarare nature of RPE65-mediated inherited retinal disease (IRD), it was not feasible to recruit a patient sample and collect HRQL da